
Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study
Taiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and tirzepatide, may offer protective benefits beyond blood sugar control in adults with type 2 diabetes and …